IBD patients have been found to have a higher risk of lymphoma.

Published Date: 26 Apr 2023

According to researchers from the Karolinska Institutet, patients with Crohn's disease and IBD have an elevated risk of developing lymphoma, and this risk has grown over the past few years.

Read Full News

Latest News

What Pet Owners Need to Know About New World Screwworm

Screwworm, a parasitic fly whose flesh-eating larvae feed on living animals, re-entered the U.S. Southwest in June for the first time since the 1970s, posing a threat to the...

Pre-Resection MRI May Incorrectly Stage Large Rectal Polyps

A small study finds that pre-resection pelvic MRI overstages more than 40% of large rectal polyps in patients referred for endoscopic resection.

Noninvasive Magnetic Therapy Effective in Fecal Incontinence

A novel noninvasive magnetic therapy is effective, safe, and well tolerated in patients with fecal incontinence, reducing symptom burden and disease severity.

Genotype-Guided Dosing Reduces Irinotecan Toxicity

Using UGT1A1 genotype to guide irinotecan dosing curbs severe side effects in patients with impaired metabolism of the drug.

Spyre Says Bowel Disease Drug Cuts Inflammation in Mid-stage Trial

Spyre Therapeutics said on Monday its experimental bowel disease drug met the main goal ⁠of significantly reducing disease severity in a mid-stage trial.

EMA Tightens Liver Safety Checks for Rare Vasculitis Drug

The EMA has reinforced enhanced liver surveillance for a vasculitis therapy after cases of severe and sometimes fatal drug-induced liver injury and vanishing bile duct syndrome.

Todays Updates

Timely ‘Nudges’ Help Spur Talks on Patient Care Goals

Simple well-timed prompts to clinicians and patients with advanced cancer can increase conversations around care goals, but clear documentation remains a challenge.

Todays Updates

Timely ‘Nudges’ Help Spur Talks on Patient Care Goals

Simple well-timed prompts to clinicians and patients with advanced cancer can increase conversations around care goals, but clear documentation remains a challenge.

Latest News

Screwworm, a parasitic fly whose flesh-eating larvae feed on living animals, re-entered the U.S. Southwest in June for the first time since the 1970s, posing a threat to the...

A small study finds that pre-resection pelvic MRI overstages more than 40% of large rectal polyps in patients referred for endoscopic resection.

A novel noninvasive magnetic therapy is effective, safe, and well tolerated in patients with fecal incontinence, reducing symptom burden and disease severity.

Using UGT1A1 genotype to guide irinotecan dosing curbs severe side effects in patients with impaired metabolism of the drug.

Spyre Therapeutics said on Monday its experimental bowel disease drug met the main goal ⁠of significantly reducing disease severity in a mid-stage trial.

The EMA has reinforced enhanced liver surveillance for a vasculitis therapy after cases of severe and sometimes fatal drug-induced liver injury and vanishing bile duct syndrome.

News All Time

Pancreatic Cancer Testing Falls Short of Goals

Researchers conducted a cross-sectional electronic survey to see whether respondents were offered and completed germline genetic testing following a pancreatic ductal adenocarcinoma diagnosis.

Pancreatic Cysts: What’s the Actual Cancer Risk?

Pancreatic cysts are common and usually considered low risk — but even those lesions signal a significantly elevated and sustained cancer risk.

UTI Treatment Shift: Is Nitrofurantoin Coming Out on Top?

A large Spanish trial reports higher cure rates with 5-day nitrofurantoin therapy than with fosfomycin or pivmecillinam in women with uncomplicated UTIs.

Takeda Engaged in Antitrust Scheme to Delay Generic Constipation Drug, US Jury Finds

A U.S. jury on Monday found Takeda Pharmaceutical liable for causing about $885 million in damages by delaying a generic version of its constipation drug Amitiza through an...

Blood Proteins Link Poor Sleep to Increased Cancer Risk

Suboptimal sleep health, reflected in low sleep proteomic scores, is consistently associated with an increased risk for cancer, particularly gastrointestinal malignancies.

Housing Instability Tied to Lower Rates of CRC Screening

Unmet health-related social needs, especially housing instability and transportation barriers, are linked to lower rates of screening for colorectal cancer among US adults.

Olanzapine Cuts Radiation-Induced Nausea

The drug, widely used for chemotherapy-related nausea, may also be highly effective for symptoms caused by abdominal-pelvic radiotherapy.

Silent Reflux: Clinical Conundrum Solved via Proper Testing

A chronic cough without heartburn are the tell-tale signs of the condition; surgery is typically not the answer.

Barrett Esophagus Onset Occurs Decades Before Diagnosis

Molecular clock modeling suggests that the biological onset of Barrett esophagus occurs more than 20 years before the recommended screening age.

Zenocutuzumab OK’d for NRG1 Fusion+ Cholangiocarcinoma

The bispecific antibody has previously granted accelerated approval for advanced, unresectable, or metastatic non-small cell lung cancer and pancreatic adenocarcinoma harboring the gene fusions.

Sigmoidoscopy Cuts Colorectal Cancer Risk in Men

Researchers randomly assign more than 100,000 adults without CRC to receive once-only sigmoidoscopy screening or no screening between 1999 and 2001. Here’s what they find.

False Positive mt-sDNA Tests Could Flag Other Cancers

False-positive multi-target stool tests are linked to higher rates of noncolorectal aerodigestive cancers, suggesting further workup may be indicated in these patients.

HER2 Testing in Practice: Case-Based Insights to Improve Interpretation, Reporting, and Multidisciplinary Team Collaboration

HER2 Testing in Practice: Case-Based Insights to Improve Interpretation, Reporting, and Multidisciplinary Team Collaboration

Meeting the Challenge of Accurate and Timely Diagnosis of GEP-NETs

Meeting the Challenge of Accurate and Timely Diagnosis of GEP-NETs

Unlocking MMR and MSI: Paving the Path to Personalized Treatment in Early-Stage CRC

Unlocking MMR and MSI: Paving the Path to Personalized Treatment in Early-Stage CRC

Precision Pathways: Matching Test Results to Therapy in Advanced G/GEJ Adenocarcinoma

Precision Pathways: Matching Test Results to Therapy in Advanced G/GEJ Adenocarcinoma

Recommended News For You

In Patients with Myeloma Who Postpone HSCT, Quadruplet Displays "Excellent Activity.".

Zebrafish models offer fast, effective guidance for personalized therapies for kids with high-risk cancer

Nasal therapeutic HPV vaccine could prevent cervical cancer

Results for Prostate Cancer Are Associated With PSA Nadir 6 Months After Primary RT.

Is global cancer care losing its human touch?

Study reveals that older women frequently receive an incorrect breast cancer diagnosis.

Older Adults With Advanced Cancer Prioritize Quality of Life

Recommended Articles For You

Minimal Residual Disease Monitoring: Advances, Clinical Relevance, and Guideline-Based Perspectives 

IL1R2 Inhibition: A New Strategy to Boost Cancer Immunity 

The Growing Challenge of Haematological Malignancies in Older Adults 

Engineering the Future of Oncology with CAR- Natural Killer Cell Design & Therapeutics 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

AI catches one-third of interval breast cancers missed at screening

2.

Novel Psychedelic Promising on Resistant Depression

3.

Colon cancer and exercise: Can physical activity reprogram genes?

4.

Research suggests peer support may lower depression, stress among cancer patients in low-resource settings

5.

FDA Expands Use of T-DXd in Early HER2+ Breast Cancer

1.

Understanding Colon Cancer: Symptoms, Causes, and Treatment Options 

2.

The Converging Frontiers of Radiation Oncology and Systemic Therapies by 2025

3.

Landmark Medical Oncology Trials Redefining Early Breast Cancer Management

4.

Cancer Staging: Updates, Clinical Insights, and Educational Resources for Medical Professionals

5.

Integrated Frameworks in Hematology in Clinical Decision-Making

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

Dacomitinib Case Presentation: Baseline Treatment and Current Status

2.

Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias

3.

Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part II

4.

Navigating the Complexities of Ph Negative ALL - Part XI

5.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot